Reply to letters: "Safety of colloids: A knowledge issue?," "update on the comparative safety of colloids: Was this review really systematic?," and "is it already time to update the comparative safety of colloids?"

Annals of Surgery

Volumn 257, Issue 1, 2013, Pages

  Groeneveld, A B Johan ^a   Navickis, Roberta J ^b   Wilkes, Mahlon M ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Hygeia Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH;

BLOOD CLOTTING; COLLOID; HUMAN; KIDNEY FUNCTION; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; SYSTEMATIC REVIEW (TOPIC);

DEXTRANS; FLUID THERAPY; GELATIN; HETASTARCH; HUMANS; RESUSCITATION; SERUM ALBUMIN;

EID: 84871624062     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31827ba25d     Document Type: Letter

References (14)

1. Groeneveld ABJ, Navickis RJ, Wilkes MM. Up-date on the comparative safety of colloids: a systematic review of clinical studies. Ann Surg. 2011;253:470-483.
2. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopul-monary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2012;144:223-230.
3. Perner A, Haase N, Guttormsen AB, et al. Hy-droxyethyl starch 130/0.4 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124-134.
4. Myburgh JA, Finfer S, Bellomo R, et al. Hydrox-yethyl starch or saline for fluid resuscitation in in-tensive care. N Engl J Med. 2012;367:1901-1911.
5. Cittanova ML, Leblanc I, Legendre C, et al. Effect ofhydroxyethyl starch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996;348:1620-1622. (Pubitemid 27007061)
6. Bellmann R, Feistritzer C, Wiedermann CJ. Ef-fect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies. Clin Pharmacokinet. 2012;51:225-236.
7. Bork K. Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol. 2005;152: 3-12.
8. Pfeifer U, Kult J, Förster H. Ascites als Komplikation hepatischer Speicherung von Hydroxyethylstärke (HES) bei Langzeit-dialyse. Klin Wochenschr. 1984;62:862-866. (Pubitemid 14029708)
9. Boldt J, Brosch C, Ducke M, et al. Influence of volume therapy with a modern hydroxyethyl starch preparation on kidney function in cardiac surgery patients with compromised renal func-tion: a comparison with human albumin. Crit Care Med. 2007;35:2740-2746. (Pubitemid 350175770)
10. Retraction in: Parrillo JE. Crit Care Med2011;39:2389.
11. Shafer SL. Shadow of doubt. Anesth Analg. 2011;112:498-500.
12. Niemi T, Schramko A, Kuitunen A, et al. Haemo-dynamics and acid-base equilibrium after cardiac surgery: comparison ofrapidly degradable hydrox-yethyl starch solutions and albumin. Scand J Surg. 2008;97:259-265.
13. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, et al. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg. 2009;108:30-36.
14. Kozek-Langenecker SA, Jungheinrich C, Sauer-mann W, et al. The effects ofhydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood prod-ucts in major surgery: a pooled analysis of random-ized clinical trials. Anesth Analg. 2008;107:382-390.